Maternal Use of Hydroxychloroquine is Associated with a Reduced Risk of Recurrent Anti-SSA/Ro Associated Cardiac Manifestations of Neonatal Lupus

Samankaltaisia teoksia

• Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
  Tekijä: Izmirly, Peter M, et al.
  Julkaistu: (2010)
• Maternal and Fetal Factors Associated with Mortality and Morbidity in a Multi-Racial/Ethnic Registry of Anti-SSA/Ro Associated Cardiac Neonatal Lupus
  Tekijä: Izmirly, Peter M., et al.
  Julkaistu: (2011)
• Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers
  Tekijä: Izmirly, Peter, et al.
  Julkaistu: (2020)
• Beta2-glycoprotein-I and Protection from Anti-SSA/Ro 60 Associated Cardiac Manifestations of Neonatal Lupus
  Tekijä: Reed, Joanne H., et al.
  Julkaistu: (2011)
• Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system
  Tekijä: Izmirly, Peter M, et al.
  Julkaistu: (2015)